Cited by 1,787

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Open access

Brookmeyer, R, Gray, S, Kawas, C·1998·American Journal of Public Health

Open this paper in CoChat — free account

Abstract

OBJECTIVES: The goal of this study was to project the future prevalence and incidence of Alzheimer's disease in the United States and the potential impact of interventions to delay disease onset. METHODS: The numbers of individuals in the United States with Alzheimer's disease and the numbers of newly diagnosed cases that can be expected over the next 50 years were estimated from a model that used age-specific incidence rates summarized from several epidemiological studies, US mortality rates, and US Bureau of the Census projections. RESULTS: in 1997, the prevalence of Alzheimer's disease in the United States was 2.32 million (range: 1.09 to 4.58 million); of these individuals, 68% were female. It is projected that the prevalence will nearly quadruple in the next 50 years, by which time approximately 1 in 45 Americans will be afflicted with the disease. Currently, the annual number of new incident cases in 360,000. If interventions could delay onset of the disease by 2 years, after 50 years there would be nearly 2 million fewer cases than projected; if onset could be delayed by 1 year, there would be nearly 800,000 fewer prevalent cases. CONCLUSIONS: As the US population ages, Alzheimer's disease will become an enormous public health problem. interventions that could delay disease onset even modestly would have a major public health impact.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2105/ajph.88.9.1337

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Self-citation
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437
Predicting Time to Nursing Home Care and Death in Individuals With Alzheimer Disease
Stern, Y. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340040030 · Cited by 359
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?
Lautenschlager, N. T., Cupples, L. A., Rao, V. S., Auerbach, S. A., Becker, R., Burke, J., Chui, H., Duara, R., Foley, E. J., Glatt, S. L., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.641 · Cited by 298

Show all 7 references

Research works printed but not linked: 41

10.1212/WNL.44.2.227 · DOI · Paper page
10.1016/0197-4580(95)00049-K · DOI · Paper page
10.1212/WNL.45.8.1441 · DOI · Paper page
10.1212/WNL.44.11.2073 · DOI · Paper page
10.1001/archneur.1994.00540210068014 · DOI · Paper page
10.1093/oxfordjournals.aje.a117244 · DOI · Paper page
10.1001/archinte.1996.00440180075009 · DOI · Paper page
10.1212/WNL.48.6.1517 · DOI · Paper page
10.1016/S0140-6736(96)03356-9 · DOI · Paper page
10.1212/WNL.40.11.1698 · DOI · Paper page
10.1001/jama.1996.03540120071037 · DOI
10.1007/BF02189530 · DOI
10.1136/jnnp.60.5.478 · DOI
10.1212/WNL.43.3_Part_1.515 · DOI · Paper page
10.1001/jama.1995.03520410048025 · DOI · Paper page
10.1212/WNL.38.6.975 · DOI
10.1212/WNL.34.7.939 · DOI · Paper page
10.1212/WNL.48.1.132 · DOI · Paper page
Vital Statistics of the United States, 1955-1958. Vol. 1. Washington, DC: Public Health Service; 1957-1960.
Vital Statistics of the United States, 1959. Vol. 1. Washington, DC: Public Health Service; 1962.
Vital Statistics of the United States, 1960-1991, Vol. 2. Washington, DC: Public Health Service; 1963-1996.
10.1093/oxfordjournals.aje.a116102 · DOI
10.2105/AJPH.84.8.1261 · DOI · Paper page
10.1377/hlthaff.12.2.164 · DOI · Paper page
10.2307/3350099 · DOI · Paper page
Evans DA, Scherr PA, Cook NR. The impact of Alzheimer's disease in the United States population. In: Suzman R, Willis D, Manton KG, eds. The Oldest Old. New York, NY: Oxford University Press Inc; 1992.
10.1001/jama.1997.03550160083043 · DOI · Paper page
10.1111/j.1600-0447.1984.tb01237.x · DOI
10.1159/000118254 · DOI
10.1093/ije/23.6.1256 · DOI
10.1192/bjp.161.2.230 · DOI · Paper page
10.1212/WNL.43.1_Part_1.13 · DOI · Paper page
10.1212/WNL.42.11.2063 · DOI
10.1212/WNL.45.9.1707 · DOI · Paper page
10.1111/j.1600-0447.1987.tb02906.x · DOI · Paper page
10.1093/ije/24.5.1000 · DOI
10.1001/jama.1997.03550160047037 · DOI · Paper page
10.1097/00002093-199601031-00002 · DOI
10.1093/ageing/21.2.91 · DOI
10.1093/oxfordjournals.aje.a117245 · DOI · Paper page
10.1016/0895-4356(96)00202-8 · DOI

Items 101–161 of 161

Effect of Curcumin-Associated and Lipid Ligand-Functionalized Nanoliposomes on Aggregation of the Alzheimer's Aβ Peptide
Taylor, M., Moore, S., Mourtas, S., Niarakis, A., Re, F., Zona, C., Ferla, B. L., Nicotra, F., Masserini, M., Antimisiaris, S. G., et al. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.06.015 · Cited by 149
Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly
Driscoll, I., Resnick, S. M., Troncoso, J. C., An, Y., O'Brien, R., & Zonderman, A. B. (2006) · Annals of Neurology · doi:10.1002/ana.21031 · Cited by 132
Asymptomatic Alzheimers Disease: A Prodrome or a State of Resilience?
Driscoll, I., & Troncoso, J. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745348 · Cited by 130
Obesity, leptin, and Alzheimer's disease
Lee, E. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06274.x · Cited by 126
Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years
Albert, M., Zhu, Y., Moghekar, A., Mori, S., Miller, M. I., Soldan, A., Pettigrew, C., Selnes, O., Li, S., & Wang, M.-C. (2018) · Brain · doi:10.1093/brain/awx365 · Cited by 118
The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohort
Tariot, P. N., Lopera, F., Langbaum, J. B., Thomas, R. G., Hendrix, S., Schneider, L. S., Rios‐Romenets, S., Giraldo, M., Acosta, N., Tobon, C., et al. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.02.002 · Cited by 128
A 2‐year follow‐up study of cigarette smoking and risk of dementia
Juan, D., Zhou, D. H. D., Li, J., Wang, J. Y. J., Gao, C., & Chen, M. (2004) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00779.x · Cited by 118
The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer’s disease
Nichols, L. O., Chang, C., Lummus, A., Burns, R., Martindale‐Adams, J., Graney, M. J., Coon, D. W., Czaja, S., & for the Resources for Enhancing Alzheimer's Caregivers Health II Investigators (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01569.x · Cited by 116
Direct medical costs and source of cost differences across the spectrum of cognitive decline: A population‐based study
Leibson, C. L., Long, K. H., Ransom, J. E., Roberts, R. O., Hass, S. L., Duhig, A. M., Smith, C. Y., Emerson, J. A., Pankratz, V. S., & Petersen, R. C. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.01.007 · Cited by 110
Demography of Informal Caregiving
Agree, E. M., & Glaser, K. (2009) · International Handbook of Population Aging · doi:10.1007/978-1-4020-8356-3_29 · Cited by 106
Cognitive lifestyle jointly predicts longitudinal cognitive decline and mortality risk
Marioni, R. E., Proust-Lima, C., Amieva, H., Brayne, C., Matthews, F. E., Dartigues, J.-F., & Jacqmin-Gadda, H. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9881-8 · Cited by 99
ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status
Vasquez, J. B., Fardo, D. W., & Estus, S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.058 · Cited by 101
The impact of alcohol on Alzheimer's disease: A systematic review
Piazza-Gardner, A. K., Gaffud, T. J. B., & Barry, A. E. (2013) · Aging & Mental Health · doi:10.1080/13607863.2012.742488 · Cited by 94
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
Vandenberghe, R., Adamczuk, K., Dupont, P., Laere, K. V., & Chételat, G. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.014 · Cited by 99
“…familial impact, the public health burden may become unsurmountable for healthcare systems over the next decades (Brookmeyer et al., 2007; Hebert et al., 2001) except if more efficacious interventions to prevent, halt or slow down Alzheimer's disease (AD) (Brookmeyer et al., 1998) are discovered.”
Background
Alzheimer's disease: The forgetting gene
Spinney, L. (2014) · Nature · doi:10.1038/510026a · Cited by 98
Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 2
Seshadri, S., Beiser, A., Au, R., Wolf, P. A., Evans, D. A., Wilson, R. S., Petersen, R. C., Knopman, D. S., Rocca, W. A., Kawas, C. H., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.002 · Cited by 97
Self-citation
Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer’s disease: an interdisciplinary perspective.
Larouche, E., Hudon, C., & Goulet, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.058 · Cited by 93
Targets for the Prevention of Dementia
Middleton, L. E., & Yaffe, K. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091657 · Cited by 94
The Thyroid in Mind: Cognitive Function and Low Thyrotropin in Older People
Gan, E. H., & Pearce, S. H. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2284 · Cited by 93
A systematic review and dose-response meta-analysis of sleep duration and the occurrence of cognitive disorders
Wu, L., Sun, D., & Tan, Y. (2018) · Sleep and Breathing · doi:10.1007/s11325-017-1527-0 · Cited by 90
Sex‐biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi‐omic analysis
Bundy, J. L., Vied, C., Badger, C., & Nowakowski, R. S. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24551 · Cited by 90
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes
Mosconi, L., Berti, V., Swerdlow, R. H., Pupi, A., Duara, R., & de Leon, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-170 · Cited by 85
Genetic background regulates -amyloid precursor protein processing and -amyloid deposition in the mouse
Lehman, E. J. H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg322 · Cited by 85
Sodium intake and physical activity impact cognitive maintenance in older adults: the NuAge Study
Fiocco, A. J., Shatenstein, B., Ferland, G., Payette, H., Belleville, S., Kergoat, M.-J., Morais, J. A., & Greenwood, C. E. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.004 · Cited by 84
ECM in brain aging and dementia
Morawski, M., Filippov, M., Tzinia, A., Tsilibary, E., & Vargova, L. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00010-4 · Cited by 84
Neuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.117 · Cited by 83
Spatial–temporal graph convolutional network for Alzheimer classification based on brain functional connectivity imaging of electroencephalogram
Shan, X., Cao, J., Huo, S., Chen, L., Sarrigiannis, P. G., & Zhao, Y. (2022) · Human Brain Mapping · doi:10.1002/hbm.25994 · Cited by 75
“Most commonly it occurs among elderly people over the age of 65, but it may also occur earlier (Brookmeyer et al., 1998, 2007).”
Background
Age-Specific Incidence Rates for Dementia and Alzheimer Disease in NIA-LOAD/NCRAD and EFIGA Families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA)
Vardarajan, B. N., Faber, K. M., Bird, T. D., Bennett, D. A., Rosenberg, R., Boeve, B. F., Graff-Radford, N. R., Goate, A. M., Farlow, M., Sweet, R. A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5570 · Cited by 73
Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
van Dijk, G., van Heijningen, S., Reijne, A. C., Nyakas, C., van der Zee, E. A., & Eisel, U. L. M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00173 · Cited by 75
Memories in the making: outcome-based evaluation of an art program for individuals with dementing illnesses
Rentz, C. A. (2002) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750201700310 · Cited by 73
Using genetics to enable studies on the prevention of Alzheimer's disease
Crenshaw, D. G., Gottschalk, W. K., Lutz, M. W., Grossman, I., Saunders, A. M., Burke, J. R., Welsh-Bohmer, K. A., Brannan, S. K., Burns, D. K., & Roses, A. D. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.222 · Cited by 70
Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions
Baker, E., & Escott-Price, V. (2020) · Frontiers in Digital Health · doi:10.3389/fdgth.2020.00014 · Cited by 71
Pathophysiology of Alzheimer’s Disease
Yarns, B. C., Holiday, K. A., Carlson, D. M., Cosgrove, C. K., & Melrose, R. J. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.07.003 · Cited by 68
Attitudes of the German general population toward early diagnosis of dementia--results of a representative telephone survey
Luck, T., Luppa, M., Sieber, J., Schomerus, G., Werner, P., König, H.-H., & Riedel-Heller, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050792 · Cited by 67
Evidence for parent of origin effect in late-onset Alzheimer disease
Bassett, S. S., Avramopoulos, D., & Fallin, D. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10648 · Cited by 66
Information and Communication Technology Systems to Improve Quality of Life and Safety of Alzheimer's Disease Patients: A Multicenter International Survey
Pilotto, A., D'Onofrio, G., Benelli, E., Zanesco, A., Cabello, A., Margelí, M. C., Wanche-Politis, S., Seferis, K., Sancarlo, D., Kilias, D., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2010-101164 · Cited by 65
Alzheimer’s Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms
Abduljawad, A. A., Elawad, M. A., Elkhalifa, M. E. M., Ahmed, A., Hamdoon, A. A. E., Salim, L. H. M., Ashraf, M., Ayaz, M., Hassan, S. S. U., & Bungau, S. (2022) · Molecules · doi:10.3390/molecules27206804 · Cited by 63
From Bedside to Bench: Does Mental and Physical Activity Promote Cognitive Vitality in Late Life?
Studenski, S., Carlson, M. C., Fillit, H., Greenough, W. T., Kramer, A., & Rebok, G. W. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.10.pe21 · Cited by 62
Internet-Based Conversational Engagement Randomized Controlled Clinical Trial (I-CONECT) Among Socially Isolated Adults 75+ Years Old With Normal Cognition or Mild Cognitive Impairment: Topline Results
Dodge, H. H., Yu, K., Wu, C.-Y., Pruitt, P. J., Asgari, M., Kaye, J. A., Hampstead, B. M., Struble, L., Potempa, K., Lichtenberg, P., et al. (2024) · The Gerontologist · doi:10.1093/geront/gnad147 · Cited by 56
Diabetes type II: A risk factor for depression-Parkinson–Alzheimer?
Riederer, P., Bartl, J., Laux, G., & Grünblatt, E. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9203-1 · Cited by 51
Predictive classification of Alzheimer’s disease using brain imaging and genetic data
Sheng, J., Xin, Y., Zhang, Q., Wang, L., Yang, Z., & Yin, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-06444-9 · Cited by 50
Is sleep disruption a risk factor for Alzheimer's disease?
Macedo, A. C., Balouch, S., & Tabet, N. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161287 · Cited by 49
Metal Nanoparticles in Alzheimer’s Disease
Behera, A., Sa, N., Pradhan, S. P., Swain, S., & Sahu, P. K. (2023) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-220112 · Cited by 50
Diagnosing dementia in the oldest-old
Brumback-Peltz, C., Balasubramanian, A. B., Corrada, M. M., & Kawas, C. H. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.07.008 · Cited by 49
Self-citation
Public knowledge about dementia in South Korea: a community-based cross-sectional survey
Seo, H.-J., Lee, D. Y., & Sung, M. R. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214001896 · Cited by 49
Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study
Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Magnetic resonance and PET studies in the early diagnosis of Alzheimer’s disease
Mosconi, L., De Santi, S., Rusinek, H., Convit, A., & de Leon, M. J. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.5.831 · Cited by 46
Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential
Mi, Y., Qi, G., Brinton, R. D., & Yin, F. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8070 · Cited by 43
Behavioral Interventions to Prevent or Delay Dementia: Protocol for a Randomized Comparative Effectiveness Study
Smith, G., Chandler, M., Locke, D. E., Fields, J., Phatak, V., Crook, J., Hanna, S., Lunde, A., Morris, M., Graff-Radford, M., et al. (2017) · JMIR Research Protocols · doi:10.2196/resprot.8103 · Cited by 42
Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer’s Risk in Female Brain
Wang, Y., Shang, Y., Mishra, A., Bacon, E., Yin, F., & Brinton, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65402-5 · Cited by 42
Plasma Homocysteine and Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Miller, J., Green, R., & Luchsinger, J. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000182421 · Cited by 38
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study
Douros, A., Santella, C., Dell’Aniello, S., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201534 · Cited by 37
Acitretin reverses early functional network degradation in a mouse model of familial Alzheimer’s disease
Rosales Jubal, E., Schwalm, M., dos Santos Guilherme, M., Schuck, F., Reinhardt, S., Tose, A., Barger, Z., Roesler, M. K., Ruffini, N., Wierczeiko, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85912-0 · Cited by 30
Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset PSEN2 families
Marchani, E. E., Bird, T. D., Steinbart, E. J., Rosenthal, E., Yu, C., Schellenberg, G. D., & Wijsman, E. M. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31072 · Cited by 29
Effects of Chinese herbal medicine fuzhisan on aged rats
Li, X. L., Wang, D. S., Zhao, B. Q., Li, Q., Qu, H. Y., Zhang, T., Zhou, J. P., & Sun, M. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.018 · Cited by 29
Autonomous Spatial Orientation in Patients with Mild to Moderate Alzheimer's Disease by using Mobile Assistive Devices: A Pilot Study
Lanza, C., Knörzer, O., Weber, M., & Riepe, M. W. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140063 · Cited by 26
Use of Genetic Variation as Biomarkers for Alzheimer's Disease
Reitz, C., & Mayeux, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04945.x · Cited by 24
Neuroprotective Properties and Therapeutic Potential of Bone Marrow–Derived Microglia in Alzheimer’s Disease
Li, C., Chen, Y.-H., & Zhang, K. (2020) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317520927169 · Cited by 17
DeepRisk: a deep learning approach for genome-wide assessment of common disease risk
Peng, J., Bao, Z., Li, J., Han, R., Wang, Y., Han, L., Peng, J., Wang, T., Hao, J., Wei, Z., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.02.015 · Cited by 15
Preclinical Alzheimer Disease: Prevention Holy Grail or Pandora's Box?: Comment on “Heavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia”
Yaffe, K. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.547 · Cited by 3
The Relationship Between the Continuum of Elevated Adiposity, Hyperinsulinemia, and Type 2 Diabetes and Late-onset Alzheimer’s Disease: An Epidemiological Perspective
Luchsinger, J. A. (2010) · Research and Perspectives in Alzheimer's Disease · doi:10.1007/978-3-642-04300-0_7 · Cited by 3

Authors: Brookmeyer, R., Gray, S., & Kawas, C.
Venue: American Journal of Public Health
Publisher: American Public Health Association
Published: 1998-09
Volume: 88
Issue: 9
Pages: 1337-1342
ISSN: 0090-0036 (ISSN-L)
1541-0048
DOI: 10.2105/ajph.88.9.1337
OpenAlex: W2125993125
Cited by: 1,787
References: 7
FWCI: 23.84
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources